This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Alberta directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $749,700
Design, synthesis and testing of oxidatively robust inhibitors for cysteine proteases in SARS2 virus and poliovirus
CIHR · 2022 · Nominated PI
- $130,575
Protein and Peptide Chromatographic Purification System with Automated Detection and Collection
NSERC · 2021 · Principal investigator
- $630,000
Mechanisms of Polyketide, Amino Acid and Polypeptide Biosynthesis
NSERC · 2020 · Principal investigator
Design, synthesis and testing of oxidatively robust inhibitors for cysteine proteases in SARS2 virus and poliovirus
Principal investigators: Vederas, John C
Keywords: Antiviral Agents; Drug Bioavailability; Drug Oxidative Metabolism; Peptide; Peptidomimetic; Poliovirus; Protease Resistance; Sars2; Structure-Activity Relationships; Viral Cysteine Proteases
Protein and Peptide Chromatographic Purification System with Automated Detection and Collection
Principal investigators: Vederas, John
Mechanisms of Polyketide, Amino Acid and Polypeptide Biosynthesis
Principal investigators: Vederas, John
Synthesis, Structural Studies and Evaluation of Inhibitors of the 3CL Protease of SARS-CoV-2 as Potential Drugs for Treating Infection
Principal investigators: Lemieux, Joanne M
Keywords: Antiviral Drugs; Development And Evaluation Of Candidate Therapeutics; Drug Design And Delivery; Enzymology; Medical Countermeasures Research; Peptide Protein Interaction; Protein Crystallography; Protein Structure; Viral Protease; Virulence
Advancing a Potent Inhibitor of SARS-CoV-2 3CL Protease into Clinical Trials
Principal investigators: Tyrrell, D. Lorne J
Keywords: Animal Disease; Antiviral Therapy; Clinical Trial; Covid-19; Feline Infectious Peritonitis; Protease Inhibitor
Design, Synthesis and Testing of Proteolytically Stable Analogs of Apelin-13 and Apelin-17 for Treatment of Cardiovascular Disease
Principal investigators: Vederas, John C
Keywords: Cardiovascular Agent; Drug Bioavailability; Drug Delivery; Peptide; Peptide Protein Interactions; Peptidomimetic; Protease Resistance; Receptor Ligand Interaction; Structure-Activity Relationships
Synthesis, Structural Studies and Evaluation of Inhibitors of the 3CL Protease of SARS-CoV-2 as Potential Drugs for Treating Infection
Principal investigators: Lemieux, MaryJoanne
Fatal attraction: Engineering and selecting beauveria bassiana fungal strains for targeted biocontrol of Mountain Pine Beetle (Dendroctonus ponderosae)**
Principal investigators: Vederas, John
Multimode Plate Reader with Fluorescent Polarization Capabilities
Principal investigators: Derda, Ratmir
Design, Production and Testing of Cladosporin Analogs to Destroy Plasmodium and Other Protozoan Pathogens by Selective Inhibition of Lysyl-tRNA Synthetases
Principal investigators: Vederas, John C
Keywords: Antimalarial; Antiprotozoal Agent; Cladosporin Analogs; Drug Bioavailability; Drug Synthesis; Enzyme Inhibitor; Lysyl Trna Synthetase; Polyketide; Structure Activity Relationships; Synthetic Biology
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.